Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

Bazhengsan reduces inflammation and tissue growth in chronic prostatitis.

Minoxidil boosts hair growth by triggering growth factor release from specific stem cells.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Finasteride causes reduced tear flow and severe eye inflammation.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

The document concludes that mouse models are helpful but have limitations for skin wound healing research, and suggests using larger animals and genetically modified mice for better human application.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

Injectable skin boosters effectively rejuvenate aging skin by improving hydration and elasticity.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Melanocytes are important for skin and hair color and protect the skin from UV damage.

Erdr1 could be a new marker for diagnosing hair loss.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

GPCRs are vital for wound healing by affecting cell growth and immune response.

Icariin can regulate macrophages and may help treat inflammation, cancer, bone disorders, and fibrotic diseases.

SH-MSCs gel reduced IL-6 and increased TGF-β, suggesting it could treat alopecia.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Immune cells are crucial for normal skin development and their dysfunction can cause skin disorders.

Innate lymphoid cells help us understand and manage allergic diseases better.